BioLight Israeli Life Sciences Investments Ltd. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com

NEW YORK, Sept. 16, 2013 /PRNewswire/ -- BioLight Israeli Life Science Investments Ltd (TASE: BOLT), a unique Biomedical firm engaged in the management and commercialization of technology in cancer diagnostics and ophthalmology, today announced its September 12th RetailInvestorConferences.com presentation is now available for on-demand viewing.  

BioLight's presentation will be available 24/7 for 90 days. Investors may download shareholder materials from the "virtual trade booth" for the next three weeks.

LINK:    www.retailinvestorconferences.com > click on the red "register/ watch event now" button

About BioLight Israeli Life Sciences Investments Ltd:

BioLight Israeli Life Sciences Investments Ltd. is a unique Biomedical firm engaged in the management and commercialization of technology in cancer diagnostics and ophthalmology. The company was founded in 2005 and as of April 21, 2011 a group led by Mr. Israel Makov gained control in the company introducing a new approach of value creation through knowledge synergies (the clusters approach).

BioLight is a public company traded on the Tel Aviv Stock Exchange (BOLT).

About RetailInvestorConferences.com:

Since 2010, RetailInvestorConferences.com has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with retail investors using a graphically-enhanced online platform.

Designed to replicate the look and feel of location-based investor conferences, Retail Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.

SOURCE BioLight Israeli Life Science Investments Ltd